![](https://www.groupdentistrynow.com/wp-content/uploads/2025/04/PK-DB-5720150-050125.jpg")
DSO Spotlight
Dr. Jason Auerbach
Dr. Jason Auerbach founded MAX Surgical Specialty Management (MAX) in 2022 with the vision to elevate patient care and transform oral surgery. His journey began with a solo practice, where he focused on hospitality as a key driver for refining processes and assembling a team dedicated to exceptional patient care. This commitment to detail and excellence laid the foundation for his broader ambitions.
While practicing as a solo practitioner, Dr. Auerbach reached a turning point when he realized that success wasn’t solely tied to his personal reputation but could be replicated through the systems and values he had built. This insight fueled his confidence to expand both geographically and at scale, driving MAX’s rapid growth across New Jersey and beyond.
Inspired by his belief that this is the golden age of oral surgery, full of opportunities to enhance both oral and systemic health, MAX has quickly grown from one to five states in the Northeast, expanding its surgeon network by nearly 40% in the past year. Today, MAX operates 29 locations across New Jersey (18), New York (4), Vermont (3), Pennsylvania (3), and Connecticut (1).
Strategic Growth and Partnerships
In January of 2025, MAX was recognized on Group Dentistry Now’s prestigious Emerging Groups to Watch list.
Now, MAX announced that it has closed on a $77 million senior credit facility provided by Freeport Financial Partners, LLC. The financing will support the next phase of the company’s strategic growth, with a focus on forming new partnerships with OMS practices across the Northeast.
“Staying close to the communities we serve is at the heart of our partnership strategy,” said Mark Censoprano, Co-CEO of MAX. “This capital allows us to expand strategically throughout the region, building relationships where they matter most. Each new partnership reinforces our position as the premier OMS support platform in the Northeast.”
“Staying close to the communities we serve is at the heart of our partnership strategy,” said Mark Censoprano, Co-CEO of MAX. “This capital allows us to expand strategically throughout the region, building relationships where they matter most. Each new partnership reinforces our position as the premier OMS support platform in the Northeast.”In conjunction with the financing, MAX has partnered with Rothman and Kim Oral & Maxillofacial Surgery (“RKOMS”), a provider in the Philadelphia market with a second location in Cinnaminson, New Jersey. For over 25 years, Marc Rothman, DMD, M. David Kim, DMD, and their team have delivered care throughout the region. RKOMS marks MAX’s second partnership in Pennsylvania.
The RKOMS partnership follows the recent addition of Oral and Maxillofacial Surgery of Westfield to MAX’s network. Under the leadership of Ronen Gold, DDS, the practice has established a strong reputation in Westfield, New Jersey, for clinical excellence and a patient-first approach. This collaboration further strengthens MAX’s growing network and solidifies its leadership position throughout New Jersey.
“MAX is assembling a network of elite oral and maxillofacial surgeons who share a vision of advancing excellence in patient care,” said Dr. Jason M. Auerbach, Founder and Co-CEO of MAX. “Drs. Rothman, Kim and Gold have spent decades building outstanding reputations in their markets. With MAX’s operational support and access to capital, they are now positioned to grow even further and continue leading innovation in the specialty.”
Since January 2024, MAX has added 14 practice locations and 17 surgeons to its network across New Jersey, New York, Pennsylvania, Vermont and Connecticut. The company’s total headcount has nearly doubled to over 300 in the last 15 months, driven by rapid expansion into new markets and investments in clinical and operational talent.
Philosophy and Market Position
The group embraces a philosophy centered on supporting those who refuse to blend in. Emphasizing innovation, bold thinking, and collaborative problem-solving, MAX creates an environment where expertise is earned, and boundaries are consistently pushed. The organization is steadfast in redefining possibilities and setting new standards in the field. They see themselves as a partner for those who demand more and want to break through limits and realize meaningful change in specialty healthcare.
In an industry dominated by remote DSO models that outsource services nationwide, MAX stands apart. While many national DSOs operate from centralized locations with limited local presence, MAX prioritizes proximity. This approach enables the organization to offer benefits that remote models may find challenging to achieve, such as increased responsiveness, seamless collaboration on patient care initiatives, rapid deployment of new technologies, and a competitive advantage in attracting top talent through valuable local market insights.
MAX’s localized support model ensures close alignment with the practices it serves. This proximity allows the company to provide tailored support in critical areas, including clinical coordination, regional operations, and marketing and referral management. By having a strong presence on the ground, they foster strong partnerships, accelerated response times, and adaptability to the needs of both patients and practices. They believe this hands-on approach is a critical factor in providing a more effective and responsive solution compared to others in today’s competitive market.
Key executives:
- Jason M. Auerbach, DDS, Founder & Co-CEO
- Mark Censoprano, Co-CEO
- Paul Olson, CFO
- Jeff DeBellis, COO
- Brian Lawson, SVP, Business Development
- Heather Paricio, SVP, Human Resources
- Rashawn Jackson, Senior Director of Marketing & Relationship Management
About the Investors and Financial Partners
MedEquity Capital
Headquartered in Wellesley, Massachusetts, MedEquity Capital is a health care private equity firm that focuses on investing in profitable health care services businesses, most often in the lower-middle market. Since its founding over 20 years ago, MedEquity has invested over $400 million of equity capital, with top decile returns for its investors.
RF Investment Partners
RF Investment Partners, a lower-middle-market private capital firm, provides innovative and flexible capital primarily for family- and founder-owned businesses. RF manages approximately $700 million and has the capabilities to provide equity and debt capital to support strategic initiatives such as acquisition financing, growth capital investments, recapitalizations, refinancings, and management buyouts.
Kian Capital Partners
Their goal is to provide flexible financial resources and additional operational horsepower to scale lower-middle-market businesses, realize aspirations and deliver long-term investment returns through genuine partnership. Kian is a private investment firm with over $1 billion of capital under management and a focus on four core industry sectors: services, value-added distribution, consumer and specialty manufacturing.
Freeport Financial
Freeport has the industry expertise, product knowledge and flexibility to serve the financing needs of private equity investors and the management teams with whom they invest. Freeport’s principals have invested together since 2005 and have provided $10 billion in loan commitments to more than 600 companies.
